Fitting a vaccine into the HIV prevention landscape

[...]the global targets are being revised for the 2025–2030 timeframe [ 1]. Except for barrier methods and adult medical male circumcision, all successful HIV prevention methods rely on antiretroviral drugs [ 4,5]. Acknowledging that the natural immunity that is induced by current HIV vaccines or HI...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the International AIDS Society 2021-11, Vol.24 (S7), p.e25792-n/a, Article 25792
Hauptverfasser:	Fauci, Anthony S., Dieffenbach, Carl W., Dabis, François
Format:	Artikel
Sprache:	eng
Schlagworte:	Acquired immune deficiency syndrome AIDS AIDS/HIV Antibodies antibody‐mediated prevention Antiretroviral agents broad neutralizing antibodies Disease prevention Drug dosages HIV HIV treatment and prevention HIV vaccine efficacy Human immunodeficiency virus Immunology Infections Infectious Diseases Life Sciences Life Sciences & Biomedicine long‐acting Pandemics Prevention pre‐exposure prophylaxis Santé publique et épidémiologie Science & Technology Severe acute respiratory syndrome coronavirus 2 Supplement: Viewpoint Vaccines
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	[...]the global targets are being revised for the 2025–2030 timeframe [ 1]. Except for barrier methods and adult medical male circumcision, all successful HIV prevention methods rely on antiretroviral drugs [ 4,5]. Acknowledging that the natural immunity that is induced by current HIV vaccines or HIV infection does not provide protection, the new tools that SARS CoV-2 can provide help to iterate vaccine strategies faster [ 15,16].
ISSN:	1758-2652 1758-2652
DOI:	10.1002/jia2.25792